Alex Kiselyov, Ph.D.
Alex is a Head of Drug Discovery at Rumi Scientific. During his 30+ year career in the pharmaceutical industry, including Amgen, ImClone/Lilly, deCODE, he contributed to multiple approved products and clinical drug candidates in the areas of neurology, neurodegeneration, neuromuscular diseases, oncology and inflammation. Alex also developed molecular and microrobotics drug delivery platforms for both pharmacological and surgical treatment of the brain. His expertise includes structure- and AI-based drug discovery, high-content phenotypic screening platforms, microfluidics, medicinal and process chemistry, CMC and regulatory aspects of drug development.
Alex received his PhD from Georgia State University and completed his postdoctoral training at the Ben May Institute for Cancer Research at the University of Chicago and Columbia University. He authored over 180 peer-reviewed publications, 7 book chapters and 80 awarded patents and patent applications. Alex is interested in the origins of Life and chirality.